Market Research Logo

Breast Imaging Market Analysis, By Technology (Ionizing Technology, Non-Ionizing Technology) And Segment Forecasts to 2024

Breast Imaging Market Analysis, By Technology (Ionizing Technology, Non-Ionizing Technology) And Segment Forecasts to 2024

The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

Further key findings from the study suggest:

The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.

North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.

Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.

Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.

In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.


Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Breast Imaging - Industry Summary and Key Buying Criteria, 2013 - 2024
Chapter 3. Breast Imaging Industry Outlook
3.1. Breast imaging market segmentation
3.2. Breast imaging market size and growth prospects, 2013 - 2024
3.3. Breast imaging market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Breast imaging : Company market share, 2015
3.7. Breast imaging market PESTEL analysis, 2015
Chapter 4. Breast Imaging Technology Outlook
4.1. Breast imaging market share, bytechnology,2015&2024
4.2. Ionizing Technologies
4.2.1. Full-Field Digital Mammography Market
4.2.1.1. Full-Field Digital Mammography Market Estimates, 2013 - 2015 (USD Million)
4.2.1.2. Full-Field Digital Mammography Market Forecasts, 2016 - 2024 (USD Million)
4.2.2. Analog Mammography Market
4.2.2.1. Analog Mammography Market Estimates, 2013 - 2015 (USD Million)
4.2.2.2. Analog Mammography Market Forecasts, 2016 - 2024 (USD Million)
4.2.3. Positron Emission Mammography Market
4.2.3.1. Positron Emission Mammography Market Estimates, 2013 - 2015 (USD Million)
4.2.3.2. Positron Emission Mammography Market Forecasts, 2016 - 2024 (USD Million)
4.2.4. Electrical Impedance Tomography Market
4.2.4.1. Electrical Impedance Tomography Market Estimates, 2013 - 2015 (USD Million)
4.2.4.2. Electrical Impedance Tomography Market Forecasts, 2016 - 2024 (USD Million)
4.2.5. Cone Beam Computed Tomography Market
4.2.5.1. Cone Beam Computed Tomography Market Estimates, 2013 - 2015(USD Million)
4.2.5.2. Cone Beam Computed Tomography Market Forecasts, 2016 - 2024 (USD Million)
4.2.6. Positron Emission Tomography & Computed Tomography Market
4.2.6.1. Positron Emission Tomography & Computed Tomography Market Estimates, 2013 - 2015 (USD Million)
4.2.6.2. Positron Emission Tomography & Computed Tomography Market Forecasts, 2016 - 2024 (USD Million)
4.2.7. 3D Breast Tomosynthesis Market
4.2.7.1. 3D Breast Tomosynthesis Market Estimates, 2013 - 2015 (USD Million)
4.2.7.2. 3D Breast Tomosynthesis Market Forecasts, 2016 - 2024 (USD Million)
4.2.8. Molecular Breast-Specific Gamma Imaging Market
4.2.8.1. Molecular breast imaging/breast-specific gamma imaging (MBI/BSGI)Market Estimates, 2013 - 2015 (USD Million)
4.2.8.2. Molecular breast imaging/breast-specific gamma imaging (MBI/BSGI)Market Forecasts, 2016 - 2024 (USD Million)
4.3. Non-Ionizing Technologies
4.3.1. Breast MRI Market
4.3.1.1. Breast MRI Market Estimates, 2013 - 2015 (USD Million)
4.3.1.2. Breast MRI Market Forecasts, 2016 - 2024 (USD Million)
4.3.2. Breast Thermography Market
4.3.2.1. Breast Thermography Market Estimates, 2013 - 2015 (USD Million)
4.3.2.2. Breast Thermography Market Forecasts, 2016 - 2024 (USD Million)
4.3.3. Breast Ultrasound Market
4.3.3.1. Breast Ultrasound Market Estimates, 2013 - 2015 (USD Million)
4.3.3.2. Breast Ultrasound Market Forecasts, 2016 - 2024 (USD Million)
4.3.4. Optical Imaging Market
4.3.4.1. Optical Imaging Market Estimates, 2013 - 2015 (USD Million)
4.3.4.2. Optical Imaging Market Forecasts, 2016 - 2024 (USD Million)
4.3.5. Automated Whole-Breast Ultrasound Market
4.3.5.1. Automated Whole-Breast Ultrasound Market Estimates, 2013 - 2015 (USD Million)
4.3.5.2. Automated Whole-Breast Ultrasound Market Forecasts, 2016 - 2024 (USD Million)
Chapter 5. Breast Imaging Regional Outlook
5.1. Breast imaging market share, byregion,2015&2024
5.2. North America
5.2.1. North America market, by technology, 2013 - 2024 (USD Million)
5.2.1.1. U.S. market estimates and forecasts
5.2.1.2. Canada market estimates and forecasts
5.3. Europe
5.3.1. Europe market, by technology, 2013 - 2024 (USD Million)
5.3.1.1. UK market estimates and forecasts
5.3.1.2. Germany market estimates and forecasts
5.4. Asia Pacific
5.4.1. Asia Pacific market, by technology, 2013 - 2024 (USD Million)
5.4.1.1. Japan market estimates and forecasts
5.4.1.2. China market estimates and forecasts
5.5. Latin America
5.5.1. Latin America market, by technology 2013 - 2024
5.5.1.1. Brazil market estimates and forecasts
5.5.1.2. Mexico market estimates and forecasts
5.6. MEA
5.6.1. MEA market, by technology 2013 - 2024
5.6.1.1. South Africa market estimates and forecasts
5.6.1.2. Saudi Arabia market estimates and forecasts
Chapter 6. Competitive Landscape
6.1. Philips Healthcare
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. Siemens Healthcare
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Gamma Medica, Inc.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. SonoCine, Inc.
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Toshiba Corporation
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Hologic, Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Fujifilms Holdings Corporation
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Dilon Technologies, Inc.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. GE Healthcare
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Aurora Imaging Technology, Inc.
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report